在全国代表性调查中无临床可检测血管视网膜病变的糖尿病患者视野丢失
研究基于2005-2008年美国国家健康与营养调查(NHANES)中接受眼底照相和FDT视野筛查的参与者,排除自报青光眼、使用青光眼药物或基于视盘特征判定青光眼者。结果显示,无糖尿病视网膜病变(DR)的糖尿病患者在5%、2%、1%概率水平出现≥1个亚视野缺损的比例均高于无糖尿病者(41.3% vs. 28.6%;27.4% vs. 17.5%;15.9% vs. 9.4%;均P < 0.0008)。多变量回归显示,在无DR的糖尿病患者中,糖化血红蛋白(HbA1c)每增加1%,出现≥1个视野亚缺损的比值增加19%(OR 1.19,95%CI 1.07-1.33;P = 0.0020)。作者认为糖尿病神经视网膜病变可能先于经典微血管病变出现。
要点
- 无DR的糖尿病患者FDT视野亚缺损率高于无糖尿病者(5%水平41.3% vs. 28.6%)。
- 无DR的糖尿病患者HbA1c每升高1%,≥1个视野亚缺损的OR为1.19(95%CI 1.07-1.33)。
- 作者认为糖尿病神经视网膜病变可能先于经典微血管病变出现。
核心结论
- 糖尿病患者在无临床可检测DR时即可出现视野缺损,提示神经视网膜病变先于经典微血管病变。
- 这些缺损随可见视网膜病变的出现而更频繁,并随视网膜病变加重而恶化。
- 需要纵向研究来理解糖尿病神经视网膜病变与经典DR相关的发病机制。
研究设计与样本
- 研究纳入2005-2008年NHANES中接受眼底照相和FDT视野筛查的所有参与者。
- 排除自报青光眼、使用青光眼药物或基于视盘特征判定青光眼者。
- 视野筛查采用FDT协议进行19个亚视野的超阈值测试。
主要发现
- 无DR的糖尿病患者在5%、2%、1%概率水平出现≥1个亚视野缺损的比例分别为41.3%、27.4%、15.9%,均高于无糖尿病者的28.6%、17.5%、9.4%(均P < 0.0008)。
- 多变量回归显示,在无DR的糖尿病患者中,HbA1c每增加1%,出现≥1个视野亚缺损的OR为1.19(95%CI 1.07-1.33;P = 0.0020)。
局限性
- 需要纵向研究来理解糖尿病神经视网膜病变与经典DR相关的发病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neuroretinopathy is increasingly being recognized as an independent cause of vision loss in diabetes. Visual field loss, as detected by frequency doubling technology (FDT)-based visual perimetry, is a sign of neuroretinopathy and occurs in early stages of diabetic retinopathy (DR). Here, we hypothesized that FDT visual field testing could identify patients with diabetic neuroretinopathy in the absence of clinically detectable microvascular DR. METHODS: All National Health and Nutrition Examination Survey (NHANES) 2005-2008 participants receiving fundus photography and visual field screening by FDT were included in this study. Participants with self-reported glaucoma, use of glaucoma medications, or determination of glaucoma based on disk features were excluded. Visual fields were screened using FDT protocol in which participants underwent a 19-subfield suprathreshold test. RESULTS: Patients with diabetes but no DR were more likely to have ≥1 subfield defects at 5%, 2%, and 1% probability levels than patients without diabetes (41.3% vs. 28.6%; 27.4% vs. 17.5%; 15.9% vs. 9.4%; all P < 0.0008). Multivariable regression showed that each additional glycated hemoglobin % (HbA1c) was associated with 19% greater odds of having ≥1 visual subfield defects in those with diabetes without DR (odds ratio: 1.19, 95% confidence interval: 1.07-1.33; P = 0.0020). CONCLUSIONS: Patients with diabetes have visual field defects in the absence of clinically detectable DR, suggesting neuroretinopathy precedes classical microvascular disease. These defects become more frequent with the onset of visible retinopathy and worsen as the retinopathy becomes more severe. Longitudinal studies are required to understand the pathogenesis of diabetic neuroretinopathy in relation to classic DR.
引用
- Bao YK, Yan Y, Gordon M, et al. Visual Field Loss in Patients With Diabetes in the Absence of Clinically-Detectable Vascular Retinopathy in a Nationally Representative Survey. Invest Ophthalmol Vis Sci. 2019. PMID: 31725170. doi:10.1167/iovs.19-28063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。